Pancreatic Cancer Basics
598 articles
Reeducating Myself About Pancreatic Cancer
Martin Hynes knew all about pancreatic cancer–as a research director he worked on the development of Gemzar. He was able to have a Whipple and is doing well.
Testing a New Immunotherapy Combo in Advanced Pancreatic Cancer
Researchers are testing an approved immunotherapy drug with a new drug that works on T cells to make it more effective for pancreatic cancer.
A New Radiation Therapy Helped Me Beat Cancer
Connie Harrington’s tumor was wrapped around an artery, eliminating surgery. After chemo, her oncologist steered her to MRI-guided radiation, which has made all the difference.
Combining Immunotherapy and Targeted Therapy for Pancreatic Cancer
Researchers are combining immunotherapy and targeted therapy in a clinical trial for pancreatic cancer patients on platinum-based chemotherapy.
New Drug Shows Positive Results in Early Trials
A new drug called PEGPH20, which helps chemotherapy drugs reach their target, is showing positive results in an ongoing pancreatic cancer trial.
Go Live Your Life
After his pancreatic cancer diagnosis, Dean Jackson took his treatment of chemotherapy, radiation, and a Whipple procedure step by step.
Changing Doctors Changed My Prognosis
When Camille Moses was diagnosed with pancreatic cancer, she realized she needed a doctor with an attitude that she could beat the disease.
Two-Year Survivor and Going Strong
Susan Hoopengarner coordinated her care between a local hospital and a major cancer center for chemotherapy and a Whipple procedure.
A Maintenance Trial for Patients with BRCA or PALB2 Mutations
A clinical trial examines whether the PARP inhibitor rucaparib can work as a maintenance drug for pancreatic cancer patients with BRCA or PALB2 mutations.
Going After a Specialized Radiation Treatment
Don Myrah wanted more than chemotherapy. He read about a specialized radiation treatment and directly contacted the company behind it.
Immunotherapy for Pancreatic Neuroendocrine Tumors
A clinical trial combines the immunotherapy drug pembrolizumab with lanreotide, a drug typically used to treat pancreatic neuroendocrine tumors.
Testing a New Drug on Advanced Pancreatic Neuroendocrine Tumors
In a clinical trial, the new drug sapanisertib is being tested for its effectiveness against pancreatic neuroendocrine tumors (PNETs).
Targeted Therapy to Inhibit Connective Tissue Growth in Pancreatic Cancer
Researchers are testing a new antibody, a type of targeted therapy, in combination with standard treatment for pancreatic cancer in a phase III trial.
Pancreatitis and Pancreatic Cancer
When Wayne was diagnosed with pancreatitis, the tests showed a very high likelihood of pancreatic cancer.
Navigating Cold and Flu Season as a Cancer Patient
Are you in treatment and planning to see friends or family for the holidays? Learn the best ways to protect yourself from cold, flu, and other viruses.